Significant Ownership of Neil Kumar

Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Neil Kumar.

Follow Filing Activity

Follow Neil Kumar and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Significant Ownership of Neil Kumar

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BBIO BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share 4.6% $689,354,243 -$87,903,790 9,282,982 -11% NEIL KUMAR 31 Mar 2026

Schedules 13D/G Reported by Neil Kumar:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.